Anne Gussow

Array ( [id] => 5385197 [patent_doc_number] => 20090226442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'RON antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/320296 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 67102 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226442.pdf [firstpage_image] =>[orig_patent_app_number] => 12320296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379280 [patent_doc_number] => 20090191119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'CANCEROUS DISEASE MODIFYING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/357012 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13375 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191119.pdf [firstpage_image] =>[orig_patent_app_number] => 12357012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528761 [patent_doc_number] => 20100015148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE UTILIZATION AND TARGETING OF OSTEOMIMICRY' [patent_app_type] => utility [patent_app_number] => 12/343063 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 25674 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015148.pdf [firstpage_image] =>[orig_patent_app_number] => 12343063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479613 [patent_doc_number] => 20090202570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/339737 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37633 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202570.pdf [firstpage_image] =>[orig_patent_app_number] => 12339737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596481 [patent_doc_number] => 07982017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same' [patent_app_type] => utility [patent_app_number] => 12/338934 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25252 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982017.pdf [firstpage_image] =>[orig_patent_app_number] => 12338934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501672 [patent_doc_number] => 20090162360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'BIVALENT, BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/332514 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14838 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162360.pdf [firstpage_image] =>[orig_patent_app_number] => 12332514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501671 [patent_doc_number] => 20090162359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'BIVALENT, BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/332486 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14918 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162359.pdf [firstpage_image] =>[orig_patent_app_number] => 12332486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580505 [patent_doc_number] => 20090175851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'BIVALENT, BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/332531 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11612 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175851.pdf [firstpage_image] =>[orig_patent_app_number] => 12332531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302876 [patent_doc_number] => 20090297528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Methods to identify compounds useful for the treatment of proliferative and differentiative disorders' [patent_app_type] => utility [patent_app_number] => 12/315862 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 56432 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297528.pdf [firstpage_image] =>[orig_patent_app_number] => 12315862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502889 [patent_doc_number] => 20090163577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/325315 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9652 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163577.pdf [firstpage_image] =>[orig_patent_app_number] => 12325315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379347 [patent_doc_number] => 20090191186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Antibodies to the PcrV Antigen of Pseudomonas aeruginosa' [patent_app_type] => utility [patent_app_number] => 12/325806 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16063 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191186.pdf [firstpage_image] =>[orig_patent_app_number] => 12325806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422450 [patent_doc_number] => 20090148905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'ANTIGEN-BINDING CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 12/324905 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 106 [patent_figures_cnt] => 106 [patent_no_of_words] => 75499 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148905.pdf [firstpage_image] =>[orig_patent_app_number] => 12324905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435604 [patent_doc_number] => 20090170191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => '84P2A9: A PROSTATE AND TESTIS SPECIFIC PROTEIN HIGHLY EXPRESSED IN PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/324707 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 38890 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170191.pdf [firstpage_image] =>[orig_patent_app_number] => 12324707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502243 [patent_doc_number] => 20090162931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS' [patent_app_type] => utility [patent_app_number] => 12/266889 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28140 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162931.pdf [firstpage_image] =>[orig_patent_app_number] => 12266889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563671 [patent_doc_number] => 20090136523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'ANTI-CD26 ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/263919 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 46186 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136523.pdf [firstpage_image] =>[orig_patent_app_number] => 12263919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545947 [patent_doc_number] => 20090155824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'METHODS FOR ANTIBODY ENGINEERING' [patent_app_type] => utility [patent_app_number] => 12/263002 [patent_app_country] => US [patent_app_date] => 2008-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155824.pdf [firstpage_image] =>[orig_patent_app_number] => 12263002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564184 [patent_doc_number] => 20090137037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'NUCLEIC ACIDS CODING FOR HUMANIZED ANTIBODIES FOR BINDING SPHINGOSINE-1-PHOSPHATE' [patent_app_type] => utility [patent_app_number] => 12/258353 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 57316 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137037.pdf [firstpage_image] =>[orig_patent_app_number] => 12258353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294589 [patent_doc_number] => 08222373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Humanized antibodies and compositions for binding sphingosine-1-phosphate' [patent_app_type] => utility [patent_app_number] => 12/258346 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 57327 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12258346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523186 [patent_doc_number] => 08026342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Compositions and methods for binding sphingosine-1-phosphate' [patent_app_type] => utility [patent_app_number] => 12/258383 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 66365 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026342.pdf [firstpage_image] =>[orig_patent_app_number] => 12258383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555648 [patent_doc_number] => 08067549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Humanized antibodies and compositions for binding sphingosine-1-phosphate' [patent_app_type] => utility [patent_app_number] => 12/258337 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 57301 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067549.pdf [firstpage_image] =>[orig_patent_app_number] => 12258337 [rel_patent_id] =>[rel_patent_doc_number] =>)